BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31625858)

  • 1. Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy.
    Medrano C; Vergez F; Mengelle C; Faguer S; Kamar N; Del Bello A
    Emerg Infect Dis; 2019 Nov; 25(11):2145-2147. PubMed ID: 31625858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive multifocal leukoencephalopathy treated with nivolumab.
    Hoang E; Bartlett NL; Goyal MS; Schmidt RE; Clifford DB
    J Neurovirol; 2019 Apr; 25(2):284-287. PubMed ID: 30864100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel treatments for progressive multifocal leukoencephalopathy.
    Bennett KM; Fernandes PM
    Br J Hosp Med (Lond); 2020 Jul; 81(7):1-9. PubMed ID: 32730143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumab.
    Uzunov M; Demeret S; Nguyen-Quoc S; Morel V; Bellanger A; Chavez H; Gasnault J; Leblond V; Roos-Weil D
    Br J Haematol; 2020 Mar; 188(6):e82-e84. PubMed ID: 31797364
    [No Abstract]   [Full Text] [Related]  

  • 5. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy.
    Beck ES; Cortese I
    Curr Opin Virol; 2020 Feb; 40():19-27. PubMed ID: 32279025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab.
    Martinot M; Ahle G; Petrosyan I; Martinez C; Gorun DM; Mohseni-Zadeh M; Fafi-Kremer S; Tebacher-Alt M
    Emerg Infect Dis; 2018 Aug; 24(8):1594-1596. PubMed ID: 30016251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy.
    Venniyoor A
    Saudi J Kidney Dis Transpl; 2019; 30(4):998-999. PubMed ID: 31464264
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?
    Roos-Weil D; Weiss N; Guihot A; Uzunov M; Bellanger A; Eymard B; Saadoun D; Houillier C; Idbaih A; Demeret S; Deback C; Leblond V; Galanaud D; Shor N; Pourcher V
    J Neurol; 2021 Jul; 268(7):2458-2465. PubMed ID: 33515299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive multifocal leukoencephalopathy: new concepts.
    Lima MA
    Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
    Holmes A; Wellings T; Walsh O; Rowlings P
    J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropathology of progressive multifocal leukoencephalopathy].
    Murayama S; Saito Y
    No To Shinkei; 2007 Feb; 59(2):119-24. PubMed ID: 17315753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen-sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximab.
    Toyoda M; Thomas D; Ahn G; Kahwaji J; Mirocha J; Chu M; Vo A; Suviolahti E; Ge S; Jordan SC
    Transpl Infect Dis; 2015 Dec; 17(6):838-47. PubMed ID: 26437369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
    Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
    N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The link between VLA-4 and JC virus reactivation.
    Monaco MC; Major EO
    Expert Rev Clin Immunol; 2012 Jan; 8(1):63-72. PubMed ID: 22149341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive multifocal leukoencephalopathy in a renal transplant patient.
    Lin TC; Wu MY; Luh HT; Lin SF; Lin CM; Tseng YC; Liu YC; Wu MS
    J Neurovirol; 2019 Aug; 25(4):612-615. PubMed ID: 31069707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progressive multifocal encephalopathy in neurological practice].
    Putilina MV; Ermoshkina NY; Sigitov IS; Sidelnikova LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):95-105. PubMed ID: 29376991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multifocal leukoencephalopathy of the brainstem in an immunocompetent patient--JC and BK polyoma-virus coinfection? A case report and review of the literature.
    Kastrup O; Göricke S; Kretzschmar H; Wauschkuhn B; Diener HC
    Clin Neurol Neurosurg; 2013 Nov; 115(11):2390-2. PubMed ID: 24094671
    [No Abstract]   [Full Text] [Related]  

  • 18. Progressive Multifocal Leukoencephalopathy Following Combined Rituximab-Based Immune-Chemotherapy for Post-transplant Lymphoproliferative Disorder in a Renal Transplant Recipient: A Case Report.
    Windpessl M; Burgstaller S; Kronbichler A; Pieringer H; Kalev O; Karrer A; Wallner M; Thaler J
    Transplant Proc; 2018 Apr; 50(3):881-883. PubMed ID: 29661457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive multifocal leukoencephalopathy.
    Weissert R
    J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease.
    Cortese I; Reich DS; Nath A
    Nat Rev Neurol; 2021 Jan; 17(1):37-51. PubMed ID: 33219338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.